Search Orphan Drug Designations and Approvals
-
Generic Name: | galinpepimut-S |
---|---|
Date Designated: | 05/08/2018 |
Orphan Designation: | Treatment of multiple myeloma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
SELLAS Life Sciences Group, Inc. 315 Madison Avenue 4th floor New York, New York 10017 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-